Trial 1B-16-9


COMPLEEMENT-1: An open-label, multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination with Letrozole for the Treatment of men and Postmenopausal Women with Hormone Receptorpositive (HR+) HER2-negative (HER2-) Advanced Breast cancer (aBC) with no prior Hormonal Therapy for Advanced Disease

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Hormone, Other
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Janice Lu, M.D.
Other Trial Staff:  Richa Aggarwal, D.M., Monica Flores, D.M., Victoria Banerjee, R.N., Grace Facio, R.N., Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.